Diligence memo · auto-generated · as of July 2, 2026
Coaxia Inc
Coaxia Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Coaxia Inc operates in Biotechnology, based in MAPLE GROVE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Coaxia Inc has raised $40M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $23M on 2009-06-19.
Most recent recorded round closed around 2009-06-19.
Valuation (modeled)modeled
Provath models Coaxia Inc at approximately $893M (range $45M–$3.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.01× the median modeled value of Series B Biotechnology companies in 2007–2009 (21 peers) — value vs value, same stage and era. Within the normal band (101% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 17.0 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 79% of Biotechnology peers (4293 compared).
Modeled value ranks above 88% of those peers.
Closest niche peers: Ion Torrent Systems Inc, PhotoThera Inc, Taligen Therapeutics Inc, Atritech Inc, Barosense Inc.
Peoplefiled
15 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.